Compositions For The Treatment Of Gastrointestinal Inflammation

Patent No. EP2211896 (titled "Compositions For The Treatment Of Gastrointestinal Inflammation") was filed by Meritage Pharma on Nov 12, 2008. The application was issued on Jan 3, 2018.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
PRUFER & PARTNER MBBOct 2, 2018PRUFER & PARTNER MBB PATENTANWALTE RECHTSANWALTE
DR FALK PHARMASep 27, 2018KELLER

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2211896

MERITAGE PHARMA
Application Number
EP08848597A
Filing Date
Nov 12, 2008
Status
Revoked
Jul 10, 2020
Publication Date
Jan 3, 2018